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Mammalian adaptation of influenza A(H7N9) virus
is limited by a narrow genetic bottleneck
Hassan Zaraket1,2,*, Tatiana Baranovich1,*, Bryan S. Kaplan1, Robert Carter3, Min-Suk Song1,w, James C. Paulson4,
Jerold E. Rehg5, Justin Bahl6, Jeri C. Crumpton1, Jon Seiler1, Michael Edmonson3, Gang Wu3, Erik Karlsson1,
Thomas Fabrizio1, Huachen Zhu7, Yi Guan7, Matloob Husain8, Stacey Schultz-Cherry1, Scott Krauss1,
Ryan McBride4, Robert G. Webster1, Elena A. Govorkova1, Jinghui Zhang3, Charles J. Russell1,9 &
Richard J. Webby1,9
Human infection with avian influenza A(H7N9) virus is associated mainly with the exposure
to infected poultry. The factors that allow interspecies transmission but limit human-to-
human transmission are unknown. Here we show that A/Anhui/1/2013(H7N9) influenza
virus infection of chickens (natural hosts) is asymptomatic and that it generates a high
genetic diversity. In contrast, diversity is tightly restricted in infected ferrets, limiting further
adaptation to a fully transmissible form. Airborne transmission in ferrets is accompanied by
the mutations in PB1, NP and NA genes that reduce viral polymerase and neuraminidase
activity. Therefore, while A(H7N9) virus can infect mammals, further adaptation appears
to incur a fitness cost. Our results reveal that a tight genetic bottleneck during avian-
to-mammalian transmission is a limiting factor in A(H7N9) influenza virus adaptation to
mammals. This previously unrecognized biological mechanism limiting species jumps
provides a measure of adaptive potential and may serve as a risk assessment tool for
pandemic preparedness.
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I
n February 2013, avian influenza A(H7N9) virus crossed the
species barrier in China and for the first time caused human
infections1. As of November 2014, 457 human infections had
been reported, with a 30% case fatality rate2. Epidemiological
evidence has linked human cases with exposure to live-bird
markets3–5. Closure of these markets, with the likely assistance of
environmental factors, helped to halt the first wave (February–
May, 2013) of the outbreak6. However, public health efforts failed
to completely stop the spread of human H7N9 infections; more
cases were reported as the second wave began in October 2013
(ref. 7) and has continued to date2.
Sporadic clusters of H7N9 virus transmission among family
members have been reported8–10; however, as yet there is no
evidence of sustained human-to-human transmission. Previous
studies have shown that airborne H7N9 virus transmission can
occur, albeit with low efficiency in ferrets11–14, the standard
model used to simulate transmissibility among humans15. Several
viral factors can contribute to the adaptability of avian-like
viruses to mammals16: virus morphology17, receptor-binding
specificity18, changes in glycosylation patterns of the
hemagglutinin (HA)19, polymerase activity20, the acid stability
of the HA21 and the HA-neuraminidase (NA) balance22.
Variation in these traits may be controlled by only a few
amino-acid substitutions in a virus genome17,20–22. Only a few
amino-acid changes are required to allow an avian-adapted virus
to become airborne-transmissible between mammals, as was
demonstrated in the influenza A(H5N1) viruses23,24.
To elucidate the transmission dynamics and transmission
barriers of the emerging H7N9 influenza viruses, we evaluated the
replication efficiency, genomic diversification and host adaptation
of A/Anhui/1/2013 (H7N9) influenza virus after the inoculation
of chickens and ferrets and during ferret-to-ferret transmission.
Here we provide evidence that H7N9 virus infection of chickens,
while asymptomatic, promotes genetic diversity in the virus
population, increasing the likelihood of substitutions that favour
mammalian infection and transmission. Conversely, the virus
shows poor airborne transmissibility and no evidence of further
adaptation upon replication in ferrets, likely due to a narrow
bottleneck constraining genetic diversification.
Results
Replication and genetic diversity in chickens. The H7N9 virus
was isolated mainly from chickens in live-bird markets suspected
to be the source of human infections. Thus, we investigated the
virulence and replication of A/Anhui/1/2013 (H7N9), one of the
first human H7N9 viruses isolated, in chickens. A/Anhui/1/2013
shares at least 99% identity at the nucleotide and protein levels
with H7N9 influenza viruses isolated from birds and live-bird
markets (Supplementary Table 1).
After intravenous injection with 10-fold dilutions of A/Anhui/
1/2013 virus stock, none of the groups of 10 chickens showed
signs of illness or succumbed to infection, indicating an
intravenous pathogenicity index of 0. We then determined the
extent and duration of virus shedding in groups of four chickens
inoculated with the A/Anhui/1/2013 virus via the natural routes
(nares, trachea and eyes). Inoculated chickens showed no signs of
illness but shed on average 3.75 log10EID50 (50% egg infectious
doses) per ml of virus from the upper respiratory tract at 3 days
post inoculation (dpi), and shedding lasted for as long as 7 dpi
(Table 1), suggesting that they can sustain H7N9 virus in the
environment with little burden to their health. We then
investigated the extent of genetic diversity of H7N9 viruses after
replication in chickens. Deep sequencing of viral RNA from
oropharyngeal swabs of inoculated birds revealed many synon-
ymous and non-synonymous mutations (see ‘chickens’, Fig. 1a;
Supplementary Data 1). All the gene segments except NS
accumulated multiple amino-acid substitutions (Supplementary
Table 2), although the HA genetic pool observed in the egg-
grown parental stock was more or less maintained. The
substantial genetic diversity, together with protracted asympto-
matic virus shedding and close human-poultry contact in live-
poultry markets, provide an optimal environment for the
generation of viruses with the ability to infect humans.
Virulence, transmission and adaptation in ferrets. We next
investigated the virus’s virulence and its transmissibility among
ferrets via contact and airborne routes. Inoculated ferrets dis-
played only transient weight loss and fever (Supplementary Fig. 1)
despite substantial (average 6.95 log10 TCID50 (50% tissue culture
infectious doses) per ml of virus on 2 dpi) and protracted
(maximum, 6 days) virus shedding from the upper respiratory
tract, as determined in nasal washes (Fig. 2a). Lung virus titres
peaked 5 dpi at an average of 105 TCID50 per gram, indicative of
substantial lower respiratory tract infection (Fig. 2d). Histological
analysis revealed mild tracheitis, bronchitis with submucosal
gland involvement and bronchoalveolar pneumonia (Fig. 3).
Minor virus replication was detected in the brain and large
intestine in one of the three inoculated ferrets (Fig. 2d). Virus
was transmitted from inoculated (donor) ferrets to three of the
four cage-mates by direct contact (DC) within 1–2 days and to
one of the four ferrets by airborne contact (AC) within 7 days
(Fig. 2b,c). Virus titres and duration of shedding were
comparable in ferrets infected by DC and AC. All the four DC
ferrets and two of the four AC ferrets became seropositive
(Supplementary Table 3). This limited mammalian transmission
by respiratory droplets is consistent with epidemiologic reports
of limited human-to-human transmission of H7N9 virus in
only a few familial clusters10 and with data from other ferret
studies11,12,14,25,26.
A second round of infection was then conducted to
investigate the properties of the airborne-transmitted H7N9
virus in ferrets. We inoculated three donor ferrets with ‘AC’
virus obtained from the nasal wash of the ferret initially
infected by airborne transmission. To further characterize the
AC virus, we measured the level of its replication in
donor ferrets and its airborne transmissibility. Ferrets inoculated
with AC virus shed virus at titres similar to those of the
ferrets inoculated with the parental (stock) virus except at 1 dpi,
when the titre was much lower in ferrets inoculated with AC
virus despite equivalent inoculum (Fig. 2e). Virus was shed
only transiently and minimally by one of the three
secondary airborne-contact ferrets, at 5 days post contact
(Fig. 2f). These findings demonstrated inefficient secondary
airborne transmissibility and poor further adaptation towards
this trait of the H7N9 virus during the previous round of
replication in a ferret host.
Table 1 | Titres of A/Anhui/1/2013 (H7N9) influenza virus
in chicken oropharyngeal swabs.
Dpi No. shedding/total Mean virus titre (log10EID50
per ml 1±s.d.)
3 4/4 3.75±1.33
5 4/4 3.94±1.54
7 2/4 1.50±0.00
10 0/4 o0.75*
Dpi, days post inoculation; No., number.
*o0.75, below the lower limit of detection. All the cloacal samples were below the lower limit of
detection.
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Genetic diversity of H7N9 viruses in ferrets. To compare
the genetic diversity generated during replication of H7N9 virus
in a mammalian versus an avian host and to screen for selection
of amino-acid substitutions after airborne transmission in
mammals, we performed deep sequence analysis of viral
RNA isolated from ferret nasal washes during both rounds
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Figure 1 | Mutation frequency in A/Anhui/1/13 (H7N9) influenza viruses collected from chickens and ferrets. (a) Heat map showing nucleotide
substitutions identified in chicken (oropharyngeal swabs) and ferret (nasal washes) virus isolates by using Illumina Mi Seq. Only mutations with a
frequency40.03 are shown. Numbers on the y axis represent the day post inoculation. (b) Mean variation frequency. Mean variation frequency for each
sample was calculated using positions that are variable in at least one of the examined samples. If a site has a minor variant frequency above zero in any of
the samples this was included in the nominator and the denominator of the proportion was the total number of variable sites that was variable in all
samples. Variation frequency was expressed as the negative log. ‘Donor ferrets Round 1’ are ferrets inoculated with parental A/Anhui/1/13 (H7N9)
influenza virus; ‘Other ferrets’ are contact ferrets in round 1 of experiments and donor ferrets in round 2. *Po0.05, two-tailed Mann–Whitney U-test.
P, parental virus; D, donor; DC, direct contact; AC, airborne contact.
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Figure 2 | Replication and transmission of A/Anhui/1/2013 (H7N9) influenza virus in ferrets. (a–c) Nasal wash virus titres in animals during round 1
experiment. Coloured bars represent individual ferrets within each group. (d) Viral titres in the tissues collected from H7N9-infected ferrets on the
indicated days post inoculation. The numbers of tissue samples with virus titres higher than the limit of detection (1.5 log10TCID50 per gram, n¼ 3) are
indicated above each bar (e,f). Nasal wash titres in round 2 experiment in which the donors were inoculated with virus previously transmitted by airborne
contact. Coloured bars represent individual ferrets within each group. NT, nasal turbinates; T, trachea; lung lobes: CrL, cranial left; CaL, caudal left;
CrR, cranial right; MR, middle right; CaR, caudal right; B, brain; Bld, blood; S, spleen; LI, large intestine.
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of the experiments. Overall, viral RNAs from ferrets were
significantly less diverse (Po0.05, two-tailed Mann–Whitney
U-test) than those isolated from chickens (Fig. 1b, Supplementary
Table 4, Supplementary Data 2) suggesting the existence
of a constraint, or narrow bottleneck, in genetic diversification
during replication in mammals. On comparing the
genetic diversity of the surface glycoproteins, we found
significantly less genetic diversity in the HA gene in ferrets
than in chickens, but no significant difference between the
diversity of the NA genes (Supplementary Fig 2). These
results suggest that a strong purifying selection pressure was
imposed on the HA gene during replication in ferrets. At the
amino-acid level, four variant residues (PB1-D76N, NP-I365V,
NA-E73K and -I300V; N9 numbering) occurred at a high fre-
quency (Z40%) in the AC isolate and were maintained in ferrets
inoculated with AC virus (Supplementary Fig 3b,e and f),
Supplementary Table 5).
Effect of selected substitutions on protein function. We next
examined the effect of substitutions present at high frequency
after airborne transmission on virus polymerase and NA activity
in vitro. In minigenome replication assays, the dual PB1-D76N
and NP-I365V substitutions reduced the polymerase activity by
23%, but single substitutions had no effect (Fig. 4a). Overall, the
polymerase activity of both the parental and mutant polymerase
complexes was significantly lower at 33 C (human upper
respiratory tract temperature) than at 37 C (avian upper
respiratory tract temperature) despite the presence of the mam-
malian-adaptive PB2-E627K substitution27. Reversing the
substitution to the avian-like PB2-627E reduced polymerase
activity markedly (to 6–8% of wild-type (WT) activity). The NA-
I300V substitution reduced NA activity by 23% (by 33% when
combined with NA-E73K) without altering its cell surface
expression (Fig. 4b,c). The negative effects of these mutations
on virus protein functions suggest that these residue changes
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Figure 3 | Histologic findings in the respiratory tracts of ferrets inoculated with A/Anhui/1/2013 (H7N9) influenza virus. Representative features
observed in tracheas (a–c), bronchi (d–f), bronchioles (g–i) and alveoli (j–o) on day 3 (a,d,g,h,i,j,k,n,o) and day 5 (b,c,e,f,l,m) post inoculation. Stains were
hematoxylin and eosin (a,b,d,g,h,j,k) or immunohistochemical stains for influenza A virus nucleoprotein (c,e,f,i,l), pneumocyte type II cells (m; surfactant
protein c), macrophages (n; ionized calcium-binding adapter molecule 1), and neutrophils (o; myeloperoxidase). Influenza A was detected in tracheas (c),
bronchi (e), submucosal glands (f), bronchioles (i) and alveolar epithelial cells (l) (blue arrows). (a–c) Tracheas showed multifocal epithelial hyperplasia
(b) and mucosal and submucosal (a,b) neutrophil and lymphocyte infiltration. (d–f) Bronchi showed multifocal epithelial hyperplasia, submucosal gland
epithelial necrosis, macrophage and neutrophil infiltration, and luminal macrophages, neutrophils and cellular debris (d, black arrow). (g–i) Bronchioles
showed epithelial necrosis (g, black arrowheads), regenerative hyperplasia (h, blue arrowhead), and marked luminal macrophage, neutrophil and
lymphocyte infiltrates admixed with cellular debris (g,h, black arrows). (j–o) Peribronchiolar alveoli (j,k) had varying degrees of pneumocyte necrosis and
regeneration (type II hyperplasia; m, black arrows), macrophage infiltration (n, black arrowheads), neutrophil infiltration (o, blue arrowheads), oedema
(k, black arrow) and cellular debris. Scale bars, 20m—h, m; 50m—a,b,c,e,f,g,i,j,k,l,n,o; 100m—d.
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either were present in the viral inoculum at low levels and their
fixation during the transmission study was somewhat stochastic
or that they had ‘hitchhiked’ along with adaptive mutations.
Replication kinetics of recombinant viruses in vitro. The
observed reduction in polymerase activity in the minireplicon
assay and the decreased NA activity in vitro suggests that an
influenza virus carrying the identified amino-acid substitutions
would be attenuated in cell culture. To assess this possibility we
generated recombinant (rg) A/Anhui/1/2013 influenza viruses
with single or multiple amino-acid substitutions in the gene/s of
interest and compared their replication kinetics with the WT rg-
virus in Madin Darby canine kidney (MDCK) cells. In line with
the drop in NA and polymerase enzymatic activities, rg-A/Anhui/
1/2013 (NAE73KþNAI300V), rg-A/Anhui/1/2013 (PB1D76Nþ
NPI365V) and rg-A/Anhui/1/2013 (NAE73KþNAI300V þ
PB1D76NþNPI365V) influenza viruses replicated to significantly
lower titres than the respective WT strain (Fig. 4d,e and f,
respectively); and the total amount of virus produced over the
course of experiment, as quantified by the area under virus titre
hour curve from 0 to 24 h (AUC0–24), was significantly lower
when compared with the WT virus (AUC0–24 71.13; 72.25; 69.19
versus 80.38 log10TCID50 per ml, respectively, Po0.05; Table 2).
These data confirmed our loss of function expectations. Viruses
with the individual amino-acid substitution in the NA,
rg-A/Anhui/1/2013 (NAE73K) and rg-A/Anhui/1/2013 (NAI300V)
viruses were significantly attenuated in vitro (Supplementary
Fig. 4a,b), as demonstrated by the total amount of virus produced
over the course of the experiment (AUC0–24 63.88; 76.20 versus
80.38 log10TCID50 per ml, respectively, Po0.05; Table 2). Virus
titres and AUC0–24 values for rg-A/Anhui/1/2013 (PB1D76N) and
rg-A/Anhui/1/2013 (NPI365V) were comparable to those of the
WT virus at 37 C (Supplementary Fig. 4c,d; Table 2). Therefore,
the observed attenuation in growth kinetics in MDCK cells could
be largely attributed to the NAE73k mutation.
Further, given these results and the minimal infection that
followed secondary airborne transmission, we concluded that the
combination of these substitutions attenuates virus replication
in vitro and does not contribute to viral transmission fitness and
that the H7N9 virus does not further adapt to mammalian hosts
upon limited replication and transmission chains.
Receptor-binding specificity. We detected six variant HA resi-
dues (Supplementary Table 5) in the stock parental A/Anhui/1/
2013 (H7N9) virus, including the L235Q mutation (L217Q in H3
numbering), which confers a human-to-avian shift in receptor-
binding preference25. The frequency of the L235Q variant
increased to B90% in one chicken isolate but was undetectable
in four of the six chicken specimens analysed. Conversely, and
against expectations, the L235Q mutation increased (albeit
slightly) in frequency in ferrets inoculated with the parental
virus but decreased in frequency among the DC ferrets. This
mutation became undetectable in the AC ferret and in ferrets
inoculated with AC samples, suggesting that the L235Q variant is
not efficiently transmitted in ferrets. In addition, three of the six
variants were completely undetectable in ferrets inoculated with
AC virus.
We then compared the binding preference of the parental and
airborne-transmitted (AC) viruses to a wide array of glycans
(Fig. 5). Both the viruses bound both avian (a-2,3–) and human
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Figure 4 | Effect of identified amino-acid substitutions in the NA, PB1 and NP on protein function and replication kinetics of recombinant A/Anhui/1/
2013 (H7N9) influenza viruses in vitro. (a) Effect of temperature on polymerase complex activity with the indicated amino-acid substitutions. (b) Effect of
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(a-2,6–) sialic acid receptors, but the AC virus’ affinity to the both
receptors was markedly reduced. This drop in binding affinity
may be due to the loss of several HA variants originally present in
the parental stock or due to the reduction in NA activity; the
cause remains to be investigated.
Acid stability of wild-type H7N9 influenza viruses. Acid stabi-
lity has been described as one of the markers for regulating host
range and virulence of influenza viruses21,23,28. We analysed the
optimal pH at which the HA protein induces syncytia formation in
infected Vero cells. The pH of HA activation of the three H7N9
viruses tested ranged between 5.6 and 5.8 (Supplementary Fig. 5).
Thus, the HA proteins from these viruses are relatively unstable
compared with those from human influenza viruses that are
typically activated at pH 5.0–5.2 (refs 29,30). The HA activation
pH values for the H7N9 viruses are more similar to those reported
for the highly pathogenic avian H5N1 influenza viruses31,32.
Discussion
Our study revealed a previously unknown population-level factor
restricting the further adaptation of avian A(H7N9) influenza
virus to mammals. Although the H7N9 virus replicates to high
titres in infected ferrets, replication in this host did not select for
viruses with enhanced growth, virulence or transmissibility. In
contrast, our data suggest that replication in ferrets lead to an
attenuated phenotype. Because adaptation depends on the extent
of the influenza virus population’s diversity in the host, we
propose the existence of a ‘genetic bottleneck’ that limits the
ability of avian A(H7N9) influenza virus to adapt to a
mammalian host by limiting its genetic diversity in that host.
By using a population-level approach and comparing the genetic
diversity of the virus population in the natural avian host and
in infected mammals, we found that the genetic diversity of
A/Anhui/1/2013 (H7N9) influenza virus was limited after its
transmission to mammals. The loss in genetic variation imposed
by the narrow genetic bottleneck appears to restrict the capacity
of A(H7N9) virus to fully adapt to mammals.
Genetic bottlenecks occur frequently during the natural life
cycles of RNA viruses33. Every RNA virus, including influenza A
virus, exists as a heterogeneous genetic pool. This genomic
diversity is an important component of influenza virus
adaptation34. The genomic diversity of the inoculum
population, the diversity generated during infection and the
diversity transferred during airborne transmission contribute to
adaptation to a given host16,35. A fully mammalian-adapted
influenza virus can cause upper respiratory infection in humans
and can be transmitted via the airborne route; the H7N9 virus
appears to have the capacity for the former but not the latter.
Avian-origin influenza viruses have the potential to cross the
species barrier and cause influenza pandemics in humans,
depending on their adaptive capacity. Our results are consistent
with the hypothesis that the adaptive potential of the A(H7N9)
virus population is limited by the loss in genetic variation from
the tight genetic bottleneck imposed by selection in the
mammalian host environment. For any given avian influenza
virus, a combination of genetic traits must be selected to enable
the adaptation to mammalian hosts. While a subpopulation of
virions in a host may possess some of these factors23,24, the
genetic bottleneck imposed on the virus population remains a
barrier to the selection and survival of those variants.
Several pieces of evidence, including the isolation of the H7N9
virus from chickens at live-bird markets and the exposure history
of infected patients, suggest that live-poultry markets are a source
of human infection4,5,36,37. Specifically, chicken layers and quail
have been shown to be susceptible to H7N9 influenza virus
infection and to shed virus at much higher titres than other avian
species, including pigeons and Pekin ducks38. Closure of live-bird
markets in China temporarily halted the H7N9 outbreak39. After
the markets reopened and the winter season began, a new wave of
infection emerged. Nearly 460 human cases had been reported as
of November 2014 (ref. 2), raising new concern about the
pandemic threat posed by this virus.
Our data show that the H7N9 virus replicates in chicken with
moderate efficiency and that the infected chickens shed virus for a
protracted period. This shedding appears to be sufficient to allow
contact transmission of H7N9 virus among chickens, although
with poor efficiency38. The ability of the H7N9 virus to replicate in
chickens is likely aided by its internal gene cassette, derived from
the H9N2 viruses of chicken origin40. The silent (asymptomatic)
replication of the virus in chickens results in undetected spread of
the H7N9 virus in the poultry markets and increases the risk of
human infection through exposure to infected, asymptomatic
chickens. Other bird species may play a role in spread of the H7N9
virus between bird markets and across provinces. One study
showed that wild birds, including finches, sparrows and parakeets,
support replication of H7N9 viruses41. The diversity generated
through replication in these hosts and the potential role they play
in H7N9 outbreaks remains to be investigated.
The human H7N9 isolates possess, or can readily acquire,
several traits that support mammalian adaptation, including the
PB2-E627K mutation42, which enhances replication in the
mammalian upper respiratory tract, promoting virulence and
airborne transmissibility24,27,43,44, and the HA-Q235L
substitution (226 in H3 numbering)45, which confers human-
like receptor preference. Indeed, the H7N9 virus replicated to
titres similar to those of human H1N1 virus (A/Brisbane/59/2007;
ref. 46) in the upper respiratory tracts of ferrets and was
Table 2 | The effect of the identified substitutions in the NA and polymerase genes on the total amount of influenza virus
produced over the course of the experiment using replication kinetic assays in MDCK cells.
rg-A/Anhui/1/2013 (H7N9) influenza virus AUC0–24 (mean log10TCID50 per ml
 1±s.d.) P value*
WT 80.38±3.11 NA
NAE73K 63.88±2.29 o0.05
NAI300V 76.20±2.26 0.07
PB1D76N 81.10±3.79 0.78
NPI365V 77.19±2.20 0.15
NAE73Kþ NAI300V 71.13±2.07 o0.05
PB1D76Nþ NPI365V 72.25±1.67 o0.05
NAE73Kþ NAI300Vþ PB1D76Nþ NPI365V 69.19±3.74 o0.05
NA, not applicable.
AUC0–24,the area under virus titre hour curve from 0 to 24 h post inoculation. Values are mean and s.d. from two independent experiments (n¼4).
*P values were compared with WT virus by two-way analysis of variance.
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transmitted to contact ferrets at a similar rate, albeit with lower
efficiency. In contrast, other avian-origin influenza viruses, such
as H5N1 virus, are not transmitted among ferrets even by
DC21,47,48. However, our results show that the mammalian
transmissibility of H7N9 virus may deteriorate rapidly and is not
sustained. Overall, the poor efficiency of H7N9 airborne
transmissibility is consistent with previous reports11,25,26. The
low transmission efficiency can be attributed to several key
properties of the H7N9 virus: (1) mixed preference for both avian
and human receptors; (2) suboptimal acid stability, with a fusion
pH optimum higher than that reported for human-transmissible
viruses23,29,49; and (3) reduced polymerase activity at the human
upper respiratory tract temperature (33 C).
The presence of a significant subpopulation of variants with the
HA mutation Q235L, which confers human receptor-binding
preference25, among the human isolates did not appear to result
in a switch to fully human receptor preference; the H7N9 virus
maintained the binding affinity for both human and avian
receptors. This result could be attributed to the presence of a
subpopulation (23%) of viruses containing the avian Q235 variant
or to the enhanced NA binding12. In the aerosol contact-
transmitted (AC) virus population, the Q235 variant population
fell too10%; the virus maintained preference for both avian and
human receptors, albeit with markedly reduced affinity,
suggesting that other residues might be masking the effect of
the Q235L mutation. Several variants (N141D, A143T and
N167D; residues 132, 134 and 158, respectively, in H3
numbering) that were present in the parental virus fell to
undetectable levels in the AC virus population and in ferrets
inoculated with the AC virus. These residues are located in the
130- and 150-loops of the receptor-binding domain (ref. 45) and
could potentially play a role in the receptor preference of H7N9
virus. Further studies are required to elucidate the effect of these
residues on receptor-binding preference and avidity.
In this study, we found that H7N9 viruses that had been
transmitted via the airborne route were not better adapted or
more transmissible in mammals than the parental strain. Four
residues in the three genes were uniquely enriched after airborne
transmission, and in the ferrets inoculated with AC virus in
round 2 experiments. Two of these substitutions (E73K and
I300V) located in the NA gene resulted in a decrease in NA
activity, and the PB1-D76N and NP-I365V mutations reduced
polymerase activity. These mutations also attenuated virus
replication in vitro. Importantly, although a human H7N9 virus
was passaged in eggs to prepare a sufficient stock for experiments,
the effect of egg-selected variants was controlled by using the
same parental strain to inoculate chickens and ferrets. Richard
et al.11 previously demonstrated the failure of H7N9 virus to
adapt to ferrets due to the selection of variants with higher avian
receptor-binding affinity, higher pH of activation and lower
thermal stability after airborne transmission. None of the
enriched variants in our study coincided with the ones
described by Richard et al.11 or with sequence heterogeneity
detected within specimens from human patients50. Thus, genetic
selection of H7N9 virus after airborne transmission is a stochastic
event and it does not favour mammalian adaptation or
mammalian transmissibility.
In comparing the genetic diversity of the surface glycoproteins,
we observed differences in genetic diversity among species in the
HA gene but not in the NA gene. At the amino-acid level, none of
the HA variants in the parental virus stock were detectable in the
transmitted virus population. This result strongly suggests that a
purifying pressure acting mainly on the HA gene (virus entry)
shapes the diversity bottleneck observed in ferrets. This purifying
pressure did not appear to select variants with novel traits such as
enhanced transmissibility of the virus in ferrets. Similar purifying
pressure on the HA gene has previously been described in
association with the airborne transmission of H5N1 virus.
However, in the case of H5N1 the purifying pressure appeared
to favour the selection of viruses with enhanced fitness after
aerosol transmission51, which was likely aided by the laboratory
forced pre-selection of a receptor-matched virus mutant before
the inoculation of ferrets24. In our study the diversity bottleneck
acting on H7N9 virus appeared to persist even after a subsequent
passage of the aerosol-transmitted virus in ferrets. Together, these
findings suggest that the H7N9 influenza virus is not readily
adaptable to transmit in mammals, which could partially explain
the absence of sustained human-to-human transmission to date.
Despite their ability to infect humans, the currently circulating
strains of H7N9 viruses did not readily acquire additional
adaptive mutations during their limited passage in humans or a
mammalian host like ferrets. Our results suggest that viral
replication in chickens may enhance the diversity of the H7N9
viruses and increase the potential of a subpopulation of variants
to enter the mammalian cells and replicate. Even though these
variants can replicate in mammals, the stringency of the genetic
bottleneck limits their ability to acquire subsequent mutations
that would allow mammal-to-mammal transmission. Whether
4,000
3,500 Parental α2,3
α2,6
AC
R
el
at
ive
 fl
uo
re
sc
en
ce
 u
ni
ts
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57
1
1,000
800
600
400
200
0
3 5 7 9 11 13 15 17 19 21 23 25 27 29
Glycan numbers
31 33 35 37 39 41 43 45 47 49 51 53 55 57
3,000
2,500
2,000
1,500
1,000
500
0
Figure 5 | Receptor-binding preference of A/Anhui/1/2013 (H7N9) influenza virus. Glycan microarray containing a2,3 and a2,6 sialosides was used to
compare the receptor-binding affinity of parental and AC (isolated on day 8 post inoculation after aerosol transmission) A/Anhui/1/2013 (H7N9) influenza
virus. Values are the means±s.d. of six replicate spots per glycan.
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such fitness enhancing variants get selected in nature is entirely
dependent on random events, frequency of infection in the new
species and time. Given the continued infection of humans with
avian H7N9 viruses, the risk of adaptation and pandemic
emergence remains plausible. Therefore, surveillance and risk
assessment of H7N9 viruses in poultry along with monitoring
infections in humans should remain a focus of pandemic
preparedness efforts.
Materials and methods
Cells. MDCK epithelial cells, African green monkey kidney epithelial (Vero)
cells and human embryonic kidney (HEK 293T) epithelial cells were obtained from
the American Type Culture Collection. MDCK cells were maintained in MEM
containing 5% heat-inactivated fetal bovine serum (FBS) and 0.5% penicillin–
streptomycin. Vero cells were maintained in DMEM (Gibco) containing 10% heat-
inactivated FBS and 2mM L-glutamine. HEK 293T cells were maintained in Opti-
MEM (Gibco, NY) supplemented with 10% heat-inactivated FBS. All the cells were
maintained at 37 C in 5% CO2.
Biosafety, biosecurity and animal care. All the experiments were performed in a
biosafety level 3 enhanced (ABSL3þ ) containment laboratory in accordance with
USDA 9 CFR 121; 7 CFR 331. All the experiments were approved by the Insti-
tutional Biosafety Committee and the Dual Use Research of Concern Sub-
committee at St Jude Children’s Research Hospital. The work in this study was
conducted prior to the current U.S. Government gain of function stop work order.
The ABSL3þ facility has security and containment features that eliminate risks to
humans and the environment28. The experiments were carried out by a trained
personnel approved for work in ABSL3þ facilities. Animal studies were approved
by the Animal Care and Use Committee of St Jude Children’s Research Hospital.
Food and water were provided ad libitum to all the animals.
Viruses. The human H7N9 viruses A/Anhui/1/2013, A/Shanghai/1/2013, and
A/Shanghai/2/2013 were obtained through the World Health Organization net-
work. The virus stock used in the chicken and ferret experiments was grown in
10-day-old embryonated chicken eggs at 35 C for 48 h.
Virus infectivity. Virus stock was titrated by plaque assay in MDCK cells at 37 C
for 72 h with a 0.4% immunodiffusion grade agarose (MP Biomedical); and by
EID50 assay in 10-day-old embryonated chicken eggs incubated at 35 C for 48 h.
Virus from chicken cloacal and oropharyngeal swabs was collected in 1-ml sterile
phosphate-buffered saline (PBS) with antibiotics, titrated in 10-day-old embryo-
nated chicken eggs at 35 C for 48 h and titrated as EID50. Virus from ferret nasal
washes and cell culture supernatants from replication kinetic experiments were
titrated in MDCK cells at 37 C for 72 h as TCID50. Virus titres (log10EID50 per ml
and log10TCID50 per ml) in nasal washes, swabs, and tissues were estimated by the
Reed and Muench method52 by using chicken red blood cells (0.5% in PBS). The
lower limit of quantitation of the assays is 0.75 log10 EID50 per ml and 1.5 log10
TCID50 per ml.
Experimental infection of chickens. Three 6-week-old, specific-pathogen-free
chickens (Gallus gallus domesticus) were inoculated with 10650% EID50 of A/
Anhui/1/2013 (H7N9) influenza virus (0.5ml) via natural routes (nares, trachea,
and eyes). Cloacal and oropharyngeal samples were collected at 3, 5, 7 and 10 dpi
with sterile cotton swabs, which were subsequently placed into 1ml of PBS with
antibiotics. Samples were stored at  80 C for subsequent titration in 10-day-old
embryonated chicken eggs as described above. The intravenous virus pathogenicity
index was determined as described by Hulse et al.53 Infective allantoic fluid was
diluted 1:10 in sterile PBS and 0.1ml was injected intravenously into each of 10 6-
week-old, specific-pathogen-free chickens. Chickens were monitored daily for 10
days for signs of illness or mortality.
Experimental infection of ferrets. Young adult (3–4- month-old) male ferrets
(Mustela putorius furo; Triple F Farms) that were serologically negative by
hemagglutination inhibition assay for currently circulating A(H1N1), A(H3N2)
and B human influenza viruses were used in the experiments. Six ferrets per group
were inoculated intranasally with 106 TCID50 of A/Anhui/1/2013 influenza virus in
0.5ml PBS under isoflurane anaesthesia. On 3 and 5 dpi, three ferrets per group
were humanely killed. Virus in the nasal cavities, tracheas, lungs, brains and the
small and large intestines was titrated in MDCK cells as the TCID50. Excised tissue
samples preserved in 10% neutral buffered formalin (Thermo Scientific) were
paraffin-embedded, sliced into 5-mm-thick sections and stained with hematoxylin
and eosin or with immunohistochemical stains for influenza A virus nucleoprotein,
pneumocyte type II cells (surfactant protein c), macrophages (ionized calcium-
binding adapter molecule 1) and neutrophils (myeloperoxidase). To collect nasal
washes, ferrets were anaesthetised by intramuscular administration of ketamine
HCl (25mg kg 1) and sterile PBS with antibiotics (0.5ml) was instilled into each
nostril. The resultant washes were collected into a sterile cup. Samples were titrated
by using the TCID50 assay in MDCK cells as described above.
Virus transmission in ferrets. Two rounds of transmission experiments were
performed. During round 1, four ferrets were inoculated intranasally with 106
TCID50 of virus in 0.5ml PBS under isoflurane anaesthesia and placed in separate
cages with directed air flow. At 1 dpi, four naı¨ve ferrets were placed in each of the
inoculated ferrets’ cages (DC) and another four ferrets were placed in AC in an
adjacent cage separated from the inoculated ferrets’ cage by a perforated divider
with controlled air flow.
For the second round of experiments (secondary respiratory droplet
transmission), six naı¨ve ferrets were inoculated with a nasal wash sample
containing ‘AC’ virus obtained at 10 dpi (day 9 post contact) from the ferret
infected via AC in the previous round of experiments. The nasal wash was diluted
in PBS to a titre ofB106 TCID50. At 1 dpi, three naı¨ve ferrets were placed in AC in
an adjacent cage as described above. Body weight and clinical signs were monitored
for 21 dpi. Virus was titrated in nasal washes collected from inoculated and AC
ferrets on 1 dpi and then every other day for 14 dpi or until no virus shedding can
be detected for two consecutive sneezes as described above.
Serologic testing. Seroconversion was tested at 20 days post contact or at 21 dpi.
Serum was treated with receptor-destroying enzyme (Seiken) overnight at 37 C to
destroy non-specific inhibitors, heat-inactivated at 56 C for 30min, and tested by
hemagglutination inhibition assay with A/Anhui/1/2013 (H7N9) virus and 0.5%
chicken red blood cells as described previously54.
Deep amplicon sequencing and genetic analysis. Viral RNA was extracted by
using an RNeasy kit (Qiagen); reverse-transcriptase PCR was then performed by
using a SuperScript III first-strand synthesis kit (Invitrogen) with the Uni12 influ-
enza primer. Multiplex PCR of all the eight gene segments was conducted by using
PCR Supermix HiFi (Invitrogen) with the Uni12/13 and influenza A polymerase
segment primers under previously described thermal cycler conditions55. PCR
products were purified on a spin column (Qiagen) and quantified by using the
Quant-It Pico Green kit (Invitrogen). DNA libraries were prepared by using
NEXTera XT DNA-Seq library prep kits (Illumina) with 96 dual-index barcodes
according to the manufacturer’s instructions. Pooled libraries were sequenced on an
Illumina MiSeq Personal Genome Sequencer, using 150 base-pair paired-end reads.
Genomic sequences were analysed by using a custom work-flow protocol. In
brief, sequence reads were filtered for quality scores by using the Nextera adapter
trimming protocol, discarding low-quality terminal bases with PHRED scores
420. A sample of 100,000 high-quality read pairs were aligned to the full set of
complete NCBI influenza genomes in an exhaustive, competitive fashion to identify
potential contaminating samples. Two rounds of alignment were performed: one
pairwise alignment and one single-end alignment of unmapped reads from the first
round. Genomes with at least one segment with a coverage40.7 were selected and
used to populate a new reference set. The full set of high-quality read pairs was
aligned to H7N9 and this reduced reference set, by using the same approach.
Genomic variations in H7N9 were detected by using an in-house single nucleotide
variants (SNV) detection pipeline that considers base quality of a putative SNV,
neighbourhood base quality, strand bias of SNV and several other factors. Heat
maps were generated by using the R programming software package (R Core Team,
2013). Mean variant frequency for each sample was calculated by using positions
that are variable in at least one of the examined samples/reads. If a site had a minor
variant frequency 40 in any of the samples, it was included in the numerator; the
denominator of the proportion was the total number of variable sites that was
variable in all samples.
Polymerase activity assays. Viral ribonucleoprotein complex genes, including
NP, PA, PB1 and PB2 of A/Anhui/1/2013 (H7N9) virus, were cloned into the
pHW2000 plasmid to test the viral polymerase activity56. The PB1-D76N, PB2-
K627E and NP-I365V mutations (primers listed in Supplementary Table 6) were
generated in pHW2000 plasmids by using a site-directed mutagenesis system
(Agilent Technologies). The polymerase activity of the mutant and wild-type
polymerase complexes was measured as previously described57. In brief, HEK 293T
cells were transfected with 0.1 mg each of pHW2000-PB2, pHW2000-PB1,
pHW2000-PA, pHW2000-NP, pHW72-Luci and pCMV-b-gal plasmids in
24-well-plates by using TransIT-LT1 transfection reagent (Mirus Bio). After 24 h,
the cells were washed with PBS and lysed for 30min with 100 ml of lysis buffer
(Promega). The cells were then collected and the luciferase activity was assayed in
triplicate by using the Promega luciferase assay system. Results were normalized to
b-galactosidase activity.
pH of HA activation. The pH of HA protein activation was measured by syn-
cytium assay, as previously described58. In brief, Vero cells were inoculated with
H7N9 influenza viruses (A/Anhui/1/2013, A/Shanghai/1/2013 and A/Shanghai/2/
2013) at a multiplicity of infection of 5 TCID50 per cell and incubated at 37 C for
18 h to allow cell surface expression of the HA protein. Cells were then washed with
PBS and treated with 5mgml 1 of TPCK (L-tosylamido 2-phenylethyl
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chloromethyl ketone)-treated trypsin (Worthington) for 5min, followed by
neutralization with FBS. Cells were then washed twice with PBS and pulsed with
PBS buffers adjusted to 0.1 pH increments by using 0.1M citric acid. The highest
pH at which syncytia were observed was recorded as the pH of HA activation.
NA activity. The activity of cell surface viral NA proteins was assayed as
previously described59. In brief, the mutations E-to-K at residue 73 and I-to-V at
residue 300 were introduced individually or in combination into the NA gene
carried in a pHW2000 plasmid by using a site-direct mutagenesis kit (Agilent
Technologies), followed by the deletion of the ClaI site and subcloning of the
product into a pCAGGS expression plasmid, using primers with overhangs that
include ClaI and NheI restriction sites (Supplementary Table 6). An HA epitope tag
was introduced into the carboxy-terminus of the NA gene during the subcloning
step using primers listed in Supplementary Table 6.
To assess the NA activity, Vero cells were transfected with the HA-tagged NA
plasmids carrying the mutations of interest (NAI300V and NAE73K), WT plasmid
and an empty pCAGGS expression plasmid (mock) by using TransIT-LTI (Mirus
Bio) transfection reagents. After incubation of the transfected cells for 20 h at 37 C,
cells were collected and resuspended in assay buffer (15mM MOPS, 145mM
sodium chloride, 2.7mM potassium chloride, and 4.0mM calcium chloride,
adjusted to pH 7.4 and supplemented with 2% heat-inactivated FBS). Fifty
microlitres of the suspension was incubated with an equal volume of 20-(4-
methylumbelliferyl)-a-D-N-acetylneuraminic acid (MUNANA; Sigma-Aldrich)
substrate (final concentration, 100mM) for 30min at 37 C. The reaction was
quenched with 100ml stop solution (150mM sodium hydroxide in 83% ethanol),
and the fluorescence intensity of the released 4-methyl-umbelliferone was
measured on a Synergy 2 multi-mode microplate reader (BioTek Instruments) with
excitation and emission wavelengths of 360 and 460 nm, respectively. NA activity
was quantified as fluorescence above the background fluorescence of mock-
transfected cells, expressed in picomoles of 4-methyl-umbelliferone product.
To confirm the cell surface expression of NA protein, the Vero cells transfected
as described above were collected, resuspended in 1X bovine serum albumin
blocking buffer in Tris-buffered saline (Thermo Scientific) and stained with
monoclonal anti-HA-FITC antibody (1:1,000 dilution; Sigma) for 1 h at 4 C. HA-
tagged NAs was then analysed by flow cytometry on a MACS Quant analyzer
(Miltenyi Biotec). The mean fluorescence intensity above that of mock-transfected
cells was quantified by FlowJo software.
Receptor-binding affinity. Glycan array analysis was performed as previously
described60, using glass slides containing 6 replicates of each of the 58 forms
(Supplementary Table 7) of sialic acid-containing glycans, including terminal
sequences, N-linked and O-linked glycans found on mammalian and avian
glycoproteins and glycolipids9. Viruses were grown in MDCK cells, inactivated
with b-propiolactone and concentrated on a sucrose gradient cushion. Viruses were
applied to the microarray slides at a concentration of 128–256 HA Uml 1. Slides
were incubated at room temperature for 1 h, washed with PBS and overlaid with
rabbit or goat anti-H7 antibody (1:200) for 1 h, followed by the addition of
10mgml 1 anti-rabbit IgG (Alexa Fluor 488) or anti-goat IgG (Alexa Fluor 647;
Invitrogen). Slides were washed and scanned on a ProScanArray Express HT
(PerkinElmer) confocal slide scanner to quantify the bound virus.
Virus rescue and replication kinetics in MDCK cells. The plasmids encoding the
eight genes of A/Anhui/1/2013 (H7N9) virus cloned into plasmid vector pHW2000
have been described in ref. 61. Amino-acid changes were introduced by using the
QuikChange site-directed mutagenesis kit (Agilent Technologies), as described
above. Recombinant (rg) rg-A/Anhui/1/2013 viruses (WT), rg-A/Anhui/1/2013
(NAE73K), rg-A/Anhui/1/2013 (NAI300V), rg-A/Anhui/1/2013 (NAE73KþNAI300V),
rg-A/Anhui/1/2013 (PB1D76N), rg-A/Anhui/1/2013 (NPI365V), rg-A/Anhui/1/2013
(PB1D76NþNPI365V) and rg-A/Anhui/1/2013 (NAE73KþNAI300V
þPB1D76NþNPI365V) were generated by co-transfecting 293T cells (TransIT-LT1,
Mirus Bio) with the appropriate eight plasmids and the virus stocks were prepared
in MDCK cells. The presence of the amino-acid substitutions of interest in the
recombinant viruses were verified by Sanger sequencing.
To determine single-step growth curves, confluent monolayers of MDCK cells
were infected with reverse-genetic viruses at an identical multiplicity of infection of
1 TCID50 per cell at 37 C. After 1 h of incubation, the cells were washed with 0.9%
aqueous NaCl solution (pH 2.2) to remove unbound virus particles, washed for
three times with PBS to adjust the pH and overlaid with infection medium (MEM
with 0.3% BSA; 1 mgml 1 TPCK-treated trypsin). Supernatants were collected at 2,
4, 6, 8, 10, 12 and 24 h post inoculation and stored at  80 C for titration in
MDCK cells as described above. To quantify the total amount of virus produced
over the course of the experiment, we computed the area under virus titre hour
curve from 0 to 24 h (AUC0–24), using peak virus titres at 0, 2, 4, 6, 8, 10, 12 and
24 h post inoculation (log10TCID50 per ml) by GraphPad software.
Statistical analysis. GraphPad Prism 5 software (GraphPad Software Inc.) was
used for statistical analysis. Two-way analysis of variance was used to compare the
groups. Two-tailed Mann–Whitney U-test was used to compare the genetic diversity.
P values o0.05 were considered to indicate a statistically significant difference.
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